Peptides
Vilon
Also called Vilon
People look at Vilon for immune support and healthy aging. Its cell research is interesting, but it does not show that a course prevents infections or makes people live longer. Online dose suggestions also vary substantially.
Dosage & duration
One supplier example; route not established in the inspected text.
NHOV research listing
Reported use · unapproved regimen- Dose
- 0.5–1 mg
- How often
- Daily
- How long
- 10 days
The seller calls this laboratory reference information. It does not establish a safe human course or a route.
Sources: 4
Why people consider Vilon
Recovery after illness and healthy aging
-
Getting back to everyday life
People researching recovery after illness are drawn to the immune-support claim.
-
Staying well with age
Fewer illnesses and healthier aging are hoped-for outcomes.
Why people consider it
Vilon is marketed as an immune “bioregulator”: something intended to influence how immune cells behave. That is the attraction for people researching recovery after illness or age-related changes in immunity.
What a course can actually promise
The inspected immune-cell experiment measured signaling in a laboratory, not illness rates or recovery in people. A seller’s short-course schedule should therefore be read as a reported example, not a proven immune reset.
Comparing it with other peptides
Vilon, Thymogen and Thymalin are different preparations. Results or dose instructions for one do not transfer automatically to the others.
Model details: Vilon · relative timing
Compare timing and buildup for this compound. The values are not blood concentrations or a measure of strength.
Shows a relative timing scenario; absolute blood concentrations are not calibrated.
Timing assumptions and sources
Legacy 4.08 h is an assumed timescale, not measured elimination.
One 1 mg input peaks at 1 relative unit after a single dose. Other amounts scale proportionally; overlapping doses add when accumulation is on. Different compounds use separate relative scales.
- Timing half-life used
- 4.08 hours
- Absorption half-life assumed
- 1.02 hours
- Reference amount for the relative scale
- 1 mg
- Absorption half-life is assumed to be one quarter of the slower timescale (1.02 h); it is not a measured absorption parameter.
- A single 1-unit input has a peak of 1 relative unit; scaling and repeated-dose addition are mathematical assumptions. This normalization is independent of the example dose.
- VilonKE, ThymogenEW and Thymalincomplex are not interchangeable.
- Culture concentrations and immune-marker changes are not blood exposure.
- Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.
Legacy 4.08 h is an assumed timescale, not measured elimination.
vilon-relative-timing-2026-10 · version 1
Common questions
Is Vilon the same as Thymalin?
No. The studies distinguish the short Vilon peptide from the Thymalin peptide mixture.
Is a 10-day course proven to strengthen immunity?
No. Short courses appear in commercial examples, but that does not establish fewer infections or durable clinical benefit.
Sources Labels, studies and notes behind this guide
Catalog evidence: Animal or laboratory research. This describes the type of evidence, not a clinical review of every claim.
Summary and fact source checks: 2026-10-07. This records source checking, not medical review of the whole page.
Notes on the quick facts
- Main interest
- A marketed goal rather than proven infection prevention.
- Course claims
- Sources disagree; no universal regimen follows from the available evidence.
- 1. Khavinson peptides in THP-1 cells, 2022
Defines Vilon KE and Thymogen EW separately; original immune-cell signaling experiment.
- 2. Fridman et al. 2020 — KE and AED in skin fibroblasts
KE effects on inflammatory and sirtuin markers in cultured skin cells; no infection-prevention endpoint.
- 3. Gene expression in aging stem-cell cultures, 2020
KE responses vary with the gene and aging model; not a uniform immune-boost or longevity result.
- 4. NHOV: Vilon supplier example
Indexed supplier text describes 0.5–1 mg daily for 10 days; route is not established by the inspected passage. Seller example, not clinical dosing evidence.
- 5. Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.
Legacy 4.08 h is an assumed timescale, not measured elimination.
Keep reading
Related compounds and examples
Related compounds
Epithalon (Epitalon)
Epithalon for sleep and longevity: reported dose ranges, Epithalamin confusion and why telomere changes do not prove longer life.
Chonluten
Chonluten is a short peptide often linked to lung-health research. A direct study found changes in inflammatory signals in laboratory immune cells; it did not test breathing or lung recovery in people.
Livagen
Livagen is a short peptide studied in liver tissue and isolated blood cells. The research describes changes in cell growth and DNA packaging, not a proven liver-detox or liver-repair treatment in people.